The IDIGH Program Management Committee consists of representatives from all three pillars of the program (fundamental research, epidemiology & health outcome and clinical research), external (non-IDIGH program) members and trainees. Our committee meets 3-4 times/year to address issues related to the program and to discuss strategies and action points to move  the IDIGH program forward towards its objective of becoming a world leading centre for translational research in infectious and immune-mediated diseases of global importance.

 

 IDIGH Program Management Meeting. Photo by Jing Liu
IDIGH Program Management Meeting. Photo by Jing Liu

Management

Dr. Erwin Schurr (Program Leader)
Dr. Marcel Behr (Associate Program Leader)

Representatives of fundamental research

Dr. Nicole Bernard
Dr. Ciriaco Piccirillo

Representatives of epidemiology & health outcome research

Dr. Theresa Gyorkos
Dr. Marina Klein
Dr. Madhukar Pai

Representatives of clinical research

Dr. Don Sheppard
Dr. Marcel Behr

Representatives of graduate students and post-doctoral fellows

Lauren Nagel (co-president of the IDIGH trainee committee)
Tho-Alfakar Al-Aubodah (co-president of the IDIGH trainee committee)

External (non-IDIGH program) members

Dr. Maziar Divangahi
Dr. Marie Hudson

IDIGH Calendar

<<  <  July 2019  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
  1  2  3  4  5  6  7
  8  91011121314
151617192021
22232425262728
293031    

Upcoming Events

Latest IDIGH Publications

  1. Dias, H. M. Y., Stallworthy, G. & Pai, M.
    (2019)
    .
    A roadmap to engage all care providers in tuberculosis prevention and care
    .
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
    ,
    vol
    .
    23
    ,
    p
    .
    641-642
    .
  2. Hart, L., Chavannes, M., Kherad, O., Maedler, C., Mourad, N., Marcus, V., Afif, W., Bitton, A., Lakatos, P. L., Brassard, P. & Bessissow, T.
    (2019)
    .
    Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis
    .
    Journal of Crohn's & colitis
  3. Morou, A., Brunet-Ratnasingham, E., Dubé, M., Charlebois, R., Mercier, E., Darko, S., Brassard, N., Nganou-Makamdop, K., Arumugam, S., Gendron-Lepage, G., Yang, L., Niessl, J., Baxter, A. E., Billingsley, J. M., Rajakumar, P. A., Lefebvre, F., Johnson, R. P., Tremblay, C., Routy, J.-P., Wyatt, R. T., Finzi, A., Douek, D. C. & Kaufmann, D. E.
    (2019)
    .
    Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease
    .
    Nature immunology
  4. Fava, V. M., Xu, Y. Z., Lettre, G., Van Thuc, N., Orlova, M., Thai, V. H., Tao, S., Croteau, N., Eldeeb, M. A., MacDougall, E. J., Cambri, G., Lahiri, R., Adams, L., Fon, E. A., Trempe, J.-F., Cobat, A., Alcaïs, A., Abel, L. & Schurr, E.
    (2019)
    .
    Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson's disease
    .
    Proceedings of the National Academy of Sciences of the United States of America
  5. Qendro, T., de la Torre, M. L., Panopalis, P., Hazel, E., Ward, B. J., Colmegna, I. & Hudson, M.
    (2019)
    .
    Suboptimal immunization coverage among Canadian rheumatology patients in routine clinical care
    .
    The Journal of rheumatology
More publications